Notes d’épisode
In this episode of The Psychedelic News Feed podcast, Psychedelic Alpha’s editor Josh Hardman runs through the last two weeks in the psychedelics field, including these stories:
• Usona Institute files its psilocybin for major depressive disorder new drug application with FDA
• FDA approves NRx Pharmaceuticals’ preservative-free generic ketamine
• We share our analysis of 610 public comments on FDA’s psychedelics docket
• ICER is set to review Compass Pathways’ psilocybin for treatment-resistant depression
• More takeaways from The Psychedelic Healthcare Forum
• Other stories
Read more:
•…
Site web: share.transistor.fm

